Technical Analysis for ENDP - Endo Health Solutions Inc.

Grade Last Price % Change Price Change
grade F 6.31 -1.87% -0.12
ENDP closed up 3.04 percent on Tuesday, May 21, 2019, on 1.2 times normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical ENDP trend table...

Date Alert Name Type % Chg
New Downtrend Bearish -1.87%
Calm After Storm Range Contraction -1.87%
Outside Day Range Expansion -1.87%
Wide Bands Range Expansion -1.87%
Lower Bollinger Band Touch Weakness -1.87%
Oversold Stochastic Weakness -1.87%
Calm After Storm Range Contraction 1.12%
Wide Bands Range Expansion 1.12%
Down 3 Days in a Row Weakness 1.12%
Gapped Down Weakness 1.12%

Older signals for ENDP ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company's Endo Pharmaceuticals segment offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel for pain, urology, endocrinology, and oncology. Its Qualitest segment provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. The company's AMS segment offers various technology solutions comprising AMS 700 MS series, AMS 800 artificial urinary sphincter, GreenLight XPS laser system, Elevate transvaginal pelvic floor repair system, and Monarc subfascial hammock products in the areas of men's and women's health, and BPH therapy. Its HealthTronics segment provides urological services, such as lithotripsy, prostate treatment, anatomical pathology, and electronic medical record services to urologists, hospitals, surgery centers, and clinics; and manufactures, sells, and maintains medical devices for tissue and tumor ablation. The company's products under development primarily include Aveed, an injectable testosterone preparation to treat male hypogonadism; BEMA Buprenorphine, a transmucosal form of buprenorphine in Phase III trials for treating moderate to severe chronic pain; ODM-201, an androgen receptor antagonist in Phase II clinical testing to treat castrate resistant prostate cancer; and EN3342, a polyurethane implant in Phase I/II trials for the maintenance treatment of schizophrenia in adults. It serves pharmacy chains directly; and hospitals, governmental agencies, pharmacies, and physicians through wholesale drug distributors. The company was formerly known as Endo Pharmaceuticals Holdings Inc. and changed its name to Endo Health Solutions Inc. in May 2012. Endo Health Solutions Inc. was founded in 1997 and is headquartered in Malvern, Pennsylvania.
Pain Surgery Chemical Compounds Organic Compounds Technology Solutions Tumor Pain Management Schizophrenia Central Nervous System Disorders Healthcare Solutions Opioids Prescription Products Severe Chronic Pain Buprenorphine Laser System Diclofenac Lithotripsy
Is ENDP a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 18.5
52 Week Low 5.93
Average Volume 3,151,738
200-Day Moving Average 11.7238
50-Day Moving Average 7.7796
20-Day Moving Average 7.3525
10-Day Moving Average 6.977
Average True Range 0.4639
ADX 26.42
+DI 11.2107
-DI 35.7568
Chandelier Exit (Long, 3 ATRs ) 7.158300000000001
Chandelier Exit (Short, 3 ATRs ) 7.3517
Upper Bollinger Band 8.6969
Lower Bollinger Band 6.0081
Percent B (%b) 0.16
BandWidth 36.569874
MACD Line -0.4043
MACD Signal Line -0.2841
MACD Histogram -0.1202
Fundamentals Value
Market Cap 1.43 Billion
Num Shares 223 Million
EPS -23.00
Price-to-Earnings (P/E) Ratio -0.28
Price-to-Sales 0.37
Price-to-Book 1.85
PEG Ratio -0.11
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.30
Resistance 3 (R3) 7.24 6.89 7.16
Resistance 2 (R2) 6.89 6.67 6.92 7.11
Resistance 1 (R1) 6.66 6.53 6.78 6.72 7.06
Pivot Point 6.31 6.31 6.37 6.34 6.31
Support 1 (S1) 6.08 6.09 6.20 6.14 5.80
Support 2 (S2) 5.73 5.95 5.76 5.75
Support 3 (S3) 5.50 5.73 5.71
Support 4 (S4) 5.56